StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$24.21+0.14 (+0.56%)

Close on Nov 17, 2026Market cap $666.15MP/E –Yield –

Fulgent Genetics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Fulgent Genetics's operating cash flow for the twelve months ending Jun 30, 2026 was -$83.70M. For fiscal 2025 it was -$101.64M, down 582.6% from the year before. The highest annual figure on record is $538.58M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$101.64M-582.6%
FY2024Dec 31, 2024$21.06M-22.0%
FY2023Dec 31, 2023$27.00M-89.3%
FY2022Dec 31, 2022$253.52M-52.9%
FY2021Dec 31, 2021$538.58M+283.0%
FY2020Dec 31, 2020$140.63M+2449.0%
FY2019Dec 31, 2019$5.52M–
FY2018Dec 31, 2018-$675.00K-150.7%
FY2017Dec 31, 2017$1.33M-69.8%
FY2016Dec 31, 2016$4.41M–
FY2015Dec 31, 2015-$969.00K–
FY2014Dec 31, 2014-$4.40M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$23.76M–
Q1 FY2026Mar 31, 2026$7.10M–
Q4 FY2025Dec 31, 2025-$78.14M-412.3%
Q3 FY2025Sep 30, 2025$11.11M–
Q2 FY2025Jun 30, 2025-$30.17M-804.1%
Q1 FY2025Mar 31, 2025-$4.43M-161.0%
Q4 FY2024Dec 31, 2024$25.02M+67.5%
Q3 FY2024Sep 30, 2024-$15.51M-251.5%
Q2 FY2024Jun 30, 2024$4.29M-56.0%
Q1 FY2024Mar 31, 2024$7.27M–
Q4 FY2023Dec 31, 2023$14.93M-55.0%
Q3 FY2023Sep 30, 2023$10.24M-50.7%
Q2 FY2023Jun 30, 2023$9.74M-12.5%
Q1 FY2023Mar 31, 2023-$7.91M-104.2%
Q4 FY2022Dec 31, 2022$33.21M-56.9%
Q3 FY2022Sep 30, 2022$20.78M-86.3%
Q2 FY2022Jun 30, 2022$11.13M-85.4%
Q1 FY2022Mar 31, 2022$188.41M-19.2%
Q4 FY2021Dec 31, 2021$77.09M-42.6%
Q3 FY2021Sep 30, 2021$152.20M+1516.6%
Q2 FY2021Jun 30, 2021$76.11M–
Q1 FY2021Mar 31, 2021$233.18M+16970.2%
Q4 FY2020Dec 31, 2020$134.26M–
Q3 FY2020Sep 30, 2020$9.42M+141.2%
Q2 FY2020Jun 30, 2020-$4.41M-753.2%
Q1 FY2020Mar 31, 2020$1.37M+29.5%
Q4 FY2019Dec 31, 2019-$116.00K-114.9%
Q3 FY2019Sep 30, 2019$3.90M–
Q2 FY2019Jun 30, 2019$675.00K–
Q1 FY2019Mar 31, 2019$1.06M–
Q4 FY2018Dec 31, 2018$778.00K–
Q3 FY2018Sep 30, 2018-$105.00K-121.0%
Q2 FY2018Jun 30, 2018-$57.00K-110.1%
Q1 FY2018Mar 31, 2018-$1.29M-185.6%
Q4 FY2017Dec 31, 2017-$1.24M-199.0%
Q3 FY2017Sep 30, 2017$500.00K-37.3%
Q2 FY2017Jun 30, 2017$564.00K–
Q1 FY2017Mar 31, 2017$1.51M–
Q4 FY2016Dec 31, 2016$1.25M–
Q3 FY2016Sep 30, 2016$798.00K–

More Fulgent Genetics figures

See a number that looks wrong?